Back
Entrada Therapeutics Vs. Fulcrum Therapeutics Industry Stock Comparison
Buy
55
TRDA
Entrada Therapeutics
Last Price:
17.81
Seasonality Move:
-29.61%
Sell
30
FULC
Fulcrum Therapeutics
Last Price:
3.01
Seasonality Move:
63.73%
Buy
55
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $17.85. The Score for TRDA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.01. The Score for FULC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $17.85
The current trend is moderately bearish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
TRDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 48.42 | Sell |
| Chaikin Money Flow: | -114809 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.96 - 19.02) | Sell |
| Bollinger Bands (100): | (14.84 - 17.78) | Buy |
FULC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 32.66 | Sell |
| Chaikin Money Flow: | -870023 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.21 - 3.57) | Sell |
| Bollinger Bands (100): | (3.52 - 8.62) | Sell |
TRDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.28 | Sell |
| 20-day SMA: | 18.12 | Sell |
| 50-day SMA: | 16.7 | Buy |
| 200-day SMA: | 15.12 | Buy |
| 8-day EMA: | 18.9 | Sell |
| 20-day EMA: | 18.31 | Sell |
| 50-day EMA: | 17.29 | Buy |
| 200-day EMA: | 15.76 | Buy |
FULC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.45 | Sell |
| 20-day SMA: | 3.34 | Sell |
| 50-day SMA: | 3.85 | Sell |
| 200-day SMA: | 7.29 | Sell |
| 8-day EMA: | 3.36 | Sell |
| 20-day EMA: | 3.44 | Sell |
| 50-day EMA: | 4.23 | Sell |
| 200-day EMA: | 6.13 | Sell |
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and a decrease next year of $0.90 per share.
Entrada Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fulcrum Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||